CompletedPhase 2NCT00259857
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Studying Idiopathic juvenile osteoporosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of South Carolina
- Principal Investigator
- Deborah A Bowlby, M.D., MDMedical University of South Carolina
- Intervention
- Alendronate(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 5-15 years · All sexes
- Timeline
- 2003 – 2009
Study locations (1)
- Medical University of South Carolina, Charleston, South Carolina, United States
Collaborators
FDA Office of Orphan Products Development · Merck Sharp & Dohme LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00259857 on ClinicalTrials.gov